Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (201-210 of 283) with videos related to

Pageof 29
Sort By:
Clinical Chemistry|June 2, 2022
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate CancerKatharina Besler, Aleksandra Węglarz, Laura Keller, et al.
Human Pathology|February 22, 2011
SOX2 amplification is a common event in squamous cell carcinomas of different organ sitesSebastian Maier, Theresia Wilbertz, Martin Braun, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progressionDavid S Rickman, Ying-Bei Chen, Samprit Banerjee, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
EML4-ALK fusion lung cancer: a rare acquired eventSven Perner, Patrick L Wagner, Francesca Demichelis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumorVeit J Scheble, Martin Braun, Rameen Beroukhim, et al.
Urologic Oncology|June 11, 2019
TRIM24 as an independent prognostic biomarker for prostate cancerAnne Offermann, Doris Roth, Marie Christine Hupe, et al.
Oncoimmunology|July 29, 2016
PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterationsAndreas H Scheel, Sascha Ansén, Anne M Schultheis, et al.
Advances in Therapy|October 23, 2020
Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World ScenarioJulian P Struck, Mario W Kramer, Olga Katzendorn, et al.
International Journal of Cancer|September 5, 2015
NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomasLydia Meder, Katharina König, Luka Ozretić, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 5, 2011
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancerTheresia Wilbertz, Patrick Wagner, Karen Petersen, et al.
Pageof 29

Showing results (201-210 of 283) with videos related to

Sort By:
Pageof 29
Clinical Chemistry|June 2, 2022
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate CancerKatharina Besler, Aleksandra Węglarz, Laura Keller, et al.
Human Pathology|February 22, 2011
SOX2 amplification is a common event in squamous cell carcinomas of different organ sitesSebastian Maier, Theresia Wilbertz, Martin Braun, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progressionDavid S Rickman, Ying-Bei Chen, Samprit Banerjee, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
EML4-ALK fusion lung cancer: a rare acquired eventSven Perner, Patrick L Wagner, Francesca Demichelis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumorVeit J Scheble, Martin Braun, Rameen Beroukhim, et al.
Urologic Oncology|June 11, 2019
TRIM24 as an independent prognostic biomarker for prostate cancerAnne Offermann, Doris Roth, Marie Christine Hupe, et al.
Oncoimmunology|July 29, 2016
PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterationsAndreas H Scheel, Sascha Ansén, Anne M Schultheis, et al.
Advances in Therapy|October 23, 2020
Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World ScenarioJulian P Struck, Mario W Kramer, Olga Katzendorn, et al.
International Journal of Cancer|September 5, 2015
NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomasLydia Meder, Katharina König, Luka Ozretić, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 5, 2011
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancerTheresia Wilbertz, Patrick Wagner, Karen Petersen, et al.
Pageof 29